Navigation Links
Product Strategies for Non-Oral Hematology Drugs
Date:3/22/2013

DUBLIN, March 22, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Product Strategies for Non-Oral Hematology Drugs" report to their offering.
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The administration of non-oral drugs for the treatment of blood disorders has evolved over the past ten years to include heparin analogs and recombinant proteins designed to treat chronic conditions that are life threatening and often debilitating illnesses. As the availability of drugs based on new APIs or molecular entities has grown, the product strategies in the marketplace have increased in specificity and sophistication.

The chronic nature of many blood diseases and the growing trend toward patient self-administration for non-oral medications is requiring drug developers and product managers to refine their product strategy at the highest level, with formulation and device selection decisions being made prior to the clinical trial phase of development.

Key Topics Covered:

Executive Summary

Therapeutic Hematology Market Dynamics
- Evolution in Drug Therapies
- Growth of Self-Administration
- Key Markets for Hematology Drug Therapeutics
- Anemia
- Deep Vein Thrombosis
- Heart Valve Prosthesis
- Neutropenia
- Pulmonary Embolism
- Competitive Landscape
- Opportunities and Risks



Non-Oral Hematology Drug Formulation and Packaging Factors
- Extended Release Formulations
- Packaging - Vial vs Prefilled Device
- Vial Strategies
- Prefilled Device Strategies
- Prefilled Syringes
- Autoinjectors
- Pen Injectors


Non-Oral Hematology Drug Administration Factors
- Dosing
- Dose Frequency
- Route of Administration
- Intravenous
- Subcutaneous

Non-Oral Hematology Drugs - Product Analysis and Market Data

Profiles of Hematology Drug Companies

For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/qg3f6l/product

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
3. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
4. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
5. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
6. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
7. National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production
8. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
9. China Biologic Products Reports Higher Results for the First Quarter 2012
10. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
11. Allied Healthcare Products Reports Loss on Sales Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... WILLIAMSTON, Mich. , Feb. 21, 2017 /PRNewswire/ ... product innovation and global patient care, is making ... management with the launch of its IRIG-8™Wound ... system enables clinicians to quickly deliver copious volumes ... constant, effective pressure. This is a significant improvement ...
(Date:2/21/2017)... 21, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Muscle Spasticity ... and benchmarks in the global Muscle Spasticity market. The ... the key drugs marketed for Muscle Spasticity and their clinical attributes? ...
(Date:2/20/2017)... Taiwan Biophotonic Co. (tBPC), a medical device ... sensing solutions, today announced the CE Marking and the ... the oCare TM Pro 100, which is a quantum ... space.  tBPC,s Wrist Pulse Oximeter, the oCare ... reliable method to measure and record heart rate and ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... A new digital ... are called back for additional examinations without sacrificing cancer detection, according to a ... the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for use ...
(Date:2/20/2017)... VA (PRWEB) , ... February 20, 2017 , ... Silverado ... Cambridge Healthcare to open and operate a state-of-the-art memory care community in Alexandria, Virginia. ... 2018 on a site just outside of Old Town. , The three-story community ...
(Date:2/20/2017)... ... February 20, 2017 , ... Clearwave is the ... on the Posiflex XT-series of touch screen terminals. Both companies will be showcasing ... Florida. The terminal provider Posiflex is helping to bridge the gap between healthcare ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... as an employee health benefit for companies that want to help members of ... providers, employees will have access to Watson’s suite of oncology offerings for insights ...
(Date:2/20/2017)... ... February 20, 2017 , ... Chuck E. Cheese’s® and ... Sundays, a joint event at Chuck E. Cheese’s locations throughout New England, New York ... needs, the opportunity to experience the fun of visiting Chuck E. Cheese’s in a ...
Breaking Medicine News(10 mins):